HSV-TK/GCV suicide gene therapy has been reported to enhance the sensitivity of glioblastoma cells to chemotherapy and radiation therapy for a synergistic effect39–41, further supporting the idea that such combination therapy may be considered earlier during treatment. The gene discussed is TKT; the disease is glioblastoma.